Market Research Report
Global Non-steroidal anti-inflammatory drugs Market 2021-2027
|Global Non-steroidal anti-inflammatory drugs Market 2021-2027|
Published: February 1, 2022
Orion Market Research Pvt Ltd
Content info: 123 Pages
Delivery time: 2-3 business days
Global Non-steroidal anti-inflammatory drugs (NSAIDs) Market Size, Share & Trends Analysis Report by Route of Administration (Oral, Parenteral) by Application (Arthritis, Migraine, Ophthalmic Diseases, Other) by Distribution channel (Hospital Pharmacies, Retail Pharmacies, Others Distribution Channels) and Forecast (2020-2026)
The global Non-steroidal anti-inflammatory drugs (NSAIDs) market is anticipated to grow at a considerable CAGR during the forecast period. The increasing prevalence of pain and inflammation causing disorders is a key factor driving the growth of the global NSAIDs market. The rising preference of NSAIDs over opioids is another major factor driving its market growth.
The global NSAIDs market is segmented based on route of administration, application, and distribution channel. Based on route of administration, the NSAIDs market is segmented into oral and parenteral. Based on application, the NSAIDs market is segmented into arthritis, migraine, ophthalmic diseases, and other. Based on distribution channel, the NSAIDs market is segmented into hospital pharmacies, retail pharmacies, and others distribution channels.
Geographically, the global NSAIDs market covers the analysis of four major regions including North America (the US and Canada), Europe (UK, Germany, Italy, Spain, France, and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), and the Rest of the World. Some of the companies operating in the global NSAIDs market include Pfizer Inc., Amgen Inc., GlaxoSmithKline PLC., Johnson & Johnson., Novartis AG., and F. Hoffmann-La Roche AG., among others.
The Report Covers